SEC Form 4 · accession 0001123292-18-000099
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Bostick
Officer — Chief Operating Officer
Period of report
Jan 2, 2018
Accepted (ET)
Jan 8, 2018 · 8:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 2, 2018 | A | 39,063 | A | — | — | Common Stock | 39,063 | 39,063 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- F2The restricted stock units vest in four equal annual installments beginning January 2, 2019.